China Resources Pharmaceutical (03320) announced the results of China Resources Shuanghe (600062.SH) for the nine months ended September 30, 2021, and from January to September 2021, the total operating income of China Resources Shuanghe was RMB6.875 billion, an increase of 7.87% year-on-year; Net profit was approximately RMB924 million, an increase of 4.8% year-on-year.